< 1 minute read
May 9, 2023

BAY 1214784 Completes Ph. I for Uterine Fibroids With Good Tolerability

BAY 1214784

oral hGnRH-R hormone receptor antagonist to treat of uterine fibroids, Ph. I completed from cell-based 2.5M cmpd HTS + opt. J. Med. Chem., Oct. 22, 2020 issue Bayer AG, Berlin, DE


Molecules of the Month

MOTY Nominees

Molecule of the Year